Ella Goldschmidt
Impact in
-
- Innovation and Socioeconomic Development
-
- T-cell and B-cell Immunology
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
Papers in
-
- Single-cell and spatial transcriptomics 1
- Oncology 2
- CAR-T cell therapy research 2
- Cancer Immunotherapy and Biomarkers 1
- Co-authors
- Asaf Madi (3 shared papers)Adi Barzel (1 shared paper)Hila Kobo (1 shared paper)Eyal Reinstein (1 shared paper)Uri Ben‐David (1 shared paper)Miriam Horovitz‐Fried (1 shared paper)Alessio D. Nahmad (1 shared paper)Eli Reuveni (1 shared paper)
- Journals
- npj Digital Medicine (1 paper)Nature Biotechnology (1 paper)Cell Reports Medicine (1 paper)Science Advances (1 paper)Regular and Young Investigator Award Abstracts (1 paper)
- Partner nations
- IsraelUnited States
In The Last Decade
Ella Goldschmidt
5 papers receiving 233 citations
Peers
Comparison fields: 5 of 48
- Business and International Management 14
- Immunology 81
- Aging 6
- Oncology 62
- Molecular Biology 111
Countries citing papers authored by Ella Goldschmidt
This map shows the geographic impact of Ella Goldschmidt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ella Goldschmidt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ella Goldschmidt more than expected).
Fields of papers citing papers by Ella Goldschmidt
This network shows the impact of papers produced by Ella Goldschmidt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ella Goldschmidt. The network helps show where Ella Goldschmidt may publish in the future.
Co-authors
The 25 scholars most cited alongside Ella Goldschmidt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 130 | |
| 2 | 2021 | 88 | |
| 3 | 2024 | 10 | |
| 4 | 2025 | 9 | |
| 5 | 2023 | 1 |
About Ella Goldschmidt
Ella Goldschmidt is a scholar working on Molecular Biology, Oncology, Epidemiology, Critical Care and Intensive Care Medicine and Biotechnology, having authored 5 papers that have together received 238 indexed citations. Recurring topics across this work include CAR-T cell therapy research (2 papers), Single-cell and spatial transcriptomics (1 paper), Microbial Inactivation Methods (1 paper), Antibiotic Use and Resistance (1 paper), Cancer Immunotherapy and Biomarkers (1 paper), Immune Cell Function and Interaction (1 paper), Immunotherapy and Immune Responses (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Business and International Management (14 citations), Immunology (81 citations), Aging (6 citations), Oncology (62 citations) and Molecular Biology (111 citations). Ella Goldschmidt has collaborated with scholars based in Israel and United States. Frequent co-authors include Asaf Madi, Adi Barzel, Hila Kobo, Eyal Reinstein, Uri Ben‐David, Miriam Horovitz‐Fried, Alessio D. Nahmad, Eli Reuveni, Rami Khosravi and Tamar Tenne. Their work appears in journals such as npj Digital Medicine, Nature Biotechnology, Cell Reports Medicine, Science Advances and Regular and Young Investigator Award Abstracts.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.